nanocarrier co ltd
(4571:Tokyo Stock Exchange)

Last --

Change Today 0.00 / 0.00%

Volume 0.0

4571 On Other Exchanges

Symbol

Exchange

4571 is not on other exchanges.

All times are local (Market data is delayed by at least 15 minutes).

nanocarrier co ltd (4571) Snapshot

Open --		Previous Close --
Day High --		Day Low --
52 Week High -- - --		52 Week Low -- - --
Market Cap --		Average Volume 10 Days 0.0
EPS TTM --		Shares Outstanding 0.0
EX-Date --		P/E TM --
Dividend --		Dividend Yield --

Current Stock Chart for NANOCARRIER CO LTD (4571)

Historical Stock Quote
Advanced Stock Chart

Related News

No related news articles were found.

nanocarrier co ltd (4571) Related Businessweek News

No Related Businessweek News Found

nanocarrier co ltd (4571) Details

NanoCarrier Co., Ltd. engages in the research, development, and production of pharmaceuticals using micellar nanoparticles technology in Japan. It focuses on the development of a pipeline of pharmaceuticals for the treatment of various types of cancers. The company’s business activities comprise in-house development, joint research and development, license-out, and sample preparation models. Its product pipeline includes Paclitaxel Micelle (NK105), which is in Phase II clinical study for the treatment of stomach cancer and in Phase III clinical study for the treatment of breast cancer; Nanoplatin (NC-6004) that is in Phase II clinical study for the treatment of pancreatic cancer; DACH-Platin Micelle (NC-4016), which is in Phase I clinical study for the treatment of solid cancer; and Epirubicin Micelle (NC-6300) that is in preclinical study for the treatment of solid cancer. The company is also developing a new pipeline of products, including Protein Micelle, siRNA Micelle, Sensor Linked Micelle, and Docetaxel Micelle that are in basic feasibility study stage. NanoCarrier Co., Ltd. was founded in 1996 and is headquartered in Kashiwa, Japan.

Detailed Company Description...

www.nanocarrier.co.jp

29 Employees
Last Reported Date: 06/29/12

Founded in 1996

nanocarrier co ltd (4571) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

nanocarrier co ltd (4571) Key Developments

NanoCarrier Co., Ltd. to Report Fiscal Year 2013 Results on May 13, 2013

May 4 13

NanoCarrier Co., Ltd. announced that they will report fiscal year 2013 results on May 13, 2013

NanoCarrier Co., Ltd., 2013 Earnings Call, May 14, 2013

May 4 13

NanoCarrier Co., Ltd., 2013 Earnings Call, May 14, 2013

NanoCarrier Co., Ltd. Reports Non-Consolidated Earnings Results for the Nine Months Ended December 31, 2012; Reaffirms Earnings Guidance for the Year Ending March 31, 2013

Feb 12 13

NanoCarrier Co., Ltd. reported non-consolidated earnings results for the nine months ended December 31, 2012. For the period, the company reported net sales of JPY 201 million against JPY 211 million for the same period last year. Operating loss was JPY 360 million against JPY 284 million for the same period last year. Net loss was JPY 356 million against JPY 288 million for the same period last year. The company reaffirmed earnings guidance for the year ending March 31, 2013. For the year, the company expects net sales of JPY 370 million, operating loss of JPY 812 million and net loss of JPY 831 million.